In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on ImmunoGen (IMGN - Research Report), with a price target of $12.00. The company's shares closed yesterday at $5.81.According to TipRanks, Ramakanth is an analyst with an average return of -8.3% and a 31.47% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Mediwound, ImmunoGen, and Precigen.ImmunoGen has an analyst consensus of Hold, with a price target consensus of $8.00.See the top stocks recommended by analysts >>The company has a one-year high of $7.77 and a one-year low of $3.10. Currently, ImmunoGen has an average volume of 3.26M.
https://www.tipranks.com/news/blurbs/immunogen-imgn-receives-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more ImmunoGen Charts.
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more ImmunoGen Charts.